top of page
.png){kind=small}
.png){kind=small}
Active Studies
Sumitomo Pharma Co., Ltd. Study
Study Details: This study is to evaluate bone mineral density with long-term use of the study drug in premenopausal women with heavy menstrual bleeding due to uterine fibroids or moderate-severe pain associated with endometriosis.
Compensation: Up to $2,600.00
Length of Study: Approximately 5 years
You may qualify if you:
-
Are a premenopausal woman 18 to 50 years of age.
-
Are willing to avoid pregnancy for 4 years using nonhormonal methods of contraception.
-
Have a diagnosis of either uterine fibroids with heavy menstrual bleeding or endometriosis with associated moderate to severe pain.
​​
Non-Hormonal Vaginal Ring Contraception
Study Details: A potential new method of birth control. A monthly non-hormonal vaginal ring for female contraception. It consists of a round piece of woven material that releases a non-hormonal agent that impedes sperm mobility and physically blocks sperm from entering the cervical canal through a unique knitted polymer barrier.
Compensation: Up to $1700.00
Length of Study: Approximately 12 - 14 months
You may qualify if you:
-
​Are a biological female between the ages of 18-40
-
Have regular menstrual cycles of 21-35 days, without heavy bleeding that lasts more than 5 days
-
Must engage is at least 4 acts of vaginal intercourse with your male partner during each menstrual cycle
-
At risk for pregnancy and desiring contraception for at least 1 year
Progesterone Only Birth Control Patch
Study Details: To determine the contraceptive efficacy of the NGMN (Progesterone only) patch when used over 13 cycles (1 year) in healthy, premenopausal, heterosexually active female participants of childbearing potential who are at risk of pregnancy.
Compensation: Up to $1175.00
Length of Study: Approximately 1 year
You may qualify if you:
-
Are a biological female, between 16-35 years of age
-
Have regular menstrual cycles of 21-35 days
-
Have heterosexual intercourse at least once per cycle; needs contraception for at least 1 year
-
Do not plan to become pregnant during the next 12 months.
Endometriosis Study
Study Details: The purpose of this study in to look at the safety and effectiveness of the study drug when taken together with a combination oral contraception.
Compensation: Up to $1600.00
Length of Study: Approximately 1 year
You may qualify if you:
-
Are a premenopausal female 18-49 years of age.​
-
Have a documented diagnosis of endometriosis.
-
Be willing to discontinue use of any prior medications for endometriosis.
-
Meet other testing criteria done in the office at your first visit.
bottom of page